{"type":"answer","id":183477,"parentType":"question","parentId":19497,"uid":24360,"contents":"<a href=\"https://www.nih.gov/news-events/news-releases/nih-clinical-trial-remdesivir-treat-covid-19-begins\" rel=\"nofollow noreferrer noopener\" target=\"_blank\">https://www.nih.gov/news-events/news-releases/nih-clinical-trial-remdesivir-treat-covid-19-begins</a><br>\n<br>\n可以参看这个网页，是National Institutes of Health (国家健康中心？有没有北美的葱油说说这个有没有官方的译名)关于Remdesivir参与肺炎治疗的基本介绍。里面谈到必须是重症患者才有资格参与临床实验。<br>\n“Participants in the NIH-sponsored trial must have laboratory-confirmed SARS-CoV-2 infection and evidence of lung involvement, including rattling sounds when breathing (rales) with a need for supplemental oxygen or abnormal chest X-rays, or illness requiring mechanical ventilation. Individuals with confirmed infection who have mild, cold-like symptoms or no apparent symptoms will not be included in the study. In accordance with standard clinical research protocols, eligible patients will provide informed consent to participate in the trial.”","date":"2020-02-29","agreeCount":0,"discussionCount":0}